| Authors: |
Garcia-Loza I; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain; Neuromuscular Diseases Group, Sant Pau Biomedical Research Institute, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Perna-Barrull D; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Aguilera E; Endocrinology Dept, Germans Trias I Pujol University Hospital, Badalona, Spain., Almenara-Fuentes L; Ahead Therapeutics SL, Barcelona, Spain., Gomez-Muñoz L; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Greco D; Ahead Therapeutics SL, Barcelona, Spain., Vila M; Ahead Therapeutics SL, Barcelona, Spain., Salvado M; Ahead Therapeutics SL, Barcelona, Spain., Mancera-Arteu M; Ahead Therapeutics SL, Barcelona, Spain., Olszowy MW; Sartorius Stedim North America, Inc., Arvada, CO, United States., Petriz J; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Dalmases M; Ahead Therapeutics SL, Barcelona, Spain., Rodriguez-Vidal S; Ahead Therapeutics SL, Barcelona, Spain., Barneda-Zahonero B; Ahead Therapeutics SL, Barcelona, Spain., Vives-Pi M; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain; Endocrinology Dept, Germans Trias I Pujol University Hospital, Badalona, Spain; Ahead Therapeutics SL, Barcelona, Spain. Electronic address: mvives@igtp.cat. |